RXFP1 and central nervous system cancer: Here, we have identified RXFP1 as a new member of a growing number of GPCRs that utilize the JAK‐STAT signaling pathways previously associated with cytokine and growth factor receptor signaling during development, inflammation, and tumorigenesis [61, 79, 80], including glioma [81].